Neurodegenerative Disease-related Phenotypes

Alzheimer's Disease (AD) risk: AD Risk (Stage 1 Results), AD Risk (Stage 2 Results)
• Kunkle, et al (2019)
Age at Onset
• Huang, et al (2017)
Progression
• Del-Aguila, et al (2018)
Amyloid Imaging
• Yan, et al (2018)
Cerebrospinal fluid (CSF) Total Tau, Phosphorylated Tau, and beta-Amyloid Peptide (1-42)
• Deming, et al (2017)
Soluble TREM2 in CSF
• Deming, et al (2018)
Neuronal Proportion QTL
• Li, et al (2020)
Parkinson’s Disease (PD)
• Nalls, et al (2019)
Frontotemporal Dementia (FTD)
• Ferrari, et al (2014)

Other Proteomic Traits

Summary statistics for 59 proteins measured in CSF using the Rules Based Medicine (RBM) Human DiscoveryMAP Panel
• Kauwe, et al (2014)

Summary statistics for 134 proteins measured in Plasma using the Rules Based Medicine (RBM) Human DiscoveryMAP Panel
• Deming, et al (2016)

Summary statistics for 1079 proteins measured in Brain, 713 proteins measured in CSF, and 931 proteins measured in Plasma using the SomaLogic SomaScan platform
• Yang, et al (under review)